Abiopharma

Mirum Pharma - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - Cingulate Inc. Filed: 2025-07-10 AccNo: 0001641172-25-018640 Size: 5 KB

New Form 3 - Cingulate Inc. Filed: 2025-07-10 AccNo: 0001641172-25-018639 Size: 12 KB

New Form S-1/A - BriaCell Therapeutics Corp. Filed: 2025-07-10 AccNo: 0001641172-25-018633 Size: 2 MB

New Form 8-K - Health Catalyst, Inc. Filed: 2025-07-10 AccNo: 0001636422-25-000096 Size: 193 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 4 - Enhabit, Inc. Filed: 2025-07-10 AccNo: 0001803737-25-000145 Size: 4 KB

New Form 4 - Enhabit, Inc. Filed: 2025-07-10 AccNo: 0001803737-25-000143 Size: 4 KB

New Form 4 - Enhabit, Inc. Filed: 2025-07-10 AccNo: 0001803737-25-000141 Size: 4 KB

New Form 4 - Enhabit, Inc. Filed: 2025-07-10 AccNo: 0001803737-25-000139 Size: 4 KB

New Form 4 - Enhabit, Inc. Filed: 2025-07-10 AccNo: 0001803737-25-000137 Size: 4 KB

New Form 4 - Enhabit, Inc. Filed: 2025-07-10 AccNo: 0001803737-25-000135 Size: 4 KB

New Form 4 - Enhabit, Inc. Filed: 2025-07-10 AccNo: 0001803737-25-000133 Size: 4 KB

New Form 4 - Oncotelic Therapeutics, Inc. Filed: 2025-07-10 AccNo: 0001641172-25-018620 Size: 9 KB

Trinseo - Trinseo Announces Release Date and Conference Call for its Second Quarter 2025 Financial Results